Impact Biomedical files Form F-4 for merger with Zoar Ltd.

Go back to Impact Biomedical files Form F-4 for merger with Zoar Ltd.

Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)

September 16, 2026 9:20 AM EDT

HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the Company or Impact) announced that a Form F-4 registration statement (the Registration Statement) was filed with the U.S. Securities and Exchange Commission (the SEC) on Thursday, September 10, 2026, by Zoar Limited (PubCo) in connection with the previously... More